ChiCTR2300073238
尚未开始
/
/
/
2023-07-05
/
/
Autism Spectrum Disorder
Autonomous social robots detect and intervene autism
Autonomous social robot improves eye contact of autistic children
To examine whether the robot-based intervention (RBI) is effective in promoting eye contact in autistic children, in comparison to the human-based intervention (HBI). There are four hypotheses. H1: Autistic children in the HBI will have fewer eye contact with the agent and less attentive duration than those in the RBI over the four-month intervention. H2: Autistic children in the HBI will be prompted more often by the agent and will be less likely to respond to the prompts than those in the RBI. H3: Autistic children in the RBI will have more eye contact with adults (their parents and human experimenter) than those in the HBI at the end of intervention. Such learning outcome will be maintained one month after the intervention. RBI is more effective for autistic children with more severe autism severity and intellectual disabilities than those with less severe autism severity and intellectual disabilities.
随机平行对照
探索性研究/预试验
In order to match the autism severity and intellectual functioning of children between both conditions, thereby reducing sampling errors due to the individual variations in these areas, we divide all children into four groups using the median split of ADOS-2 and WPPSI-4 that measure autism severity and intellectual functioning respectively (high ADOS-2 and low WPPSI-4; low ADOS-2 and low WPPSI-4; high ADOS-2 and high WPPSI-4; low ADOS-2 and high WPPSI-4). Then we randomly assign the children in each group to the two conditions, such that the final sample for each of the two conditions has the same proportion of samples from each group.
None
RGC General Research Fund
/
75
/
2023-07-01
2026-06-30
/
1. Have their diagnoses of being on the autism spectrum confirmed by a trained professional who had completed ADOS-2 (Autism Diagnostic Observation Schedule - 2nd edition, Lord, 2012) Advanced/Research Training; 2. Have no hearing or vision impairment; 3. Can follow simple commands (e.g., "No", "Come here"); 4. Are aged 4-6; 5. Have IQs 50 or above (WPPSI-4th edition; Wechsler Preschool and Primary Scale of Intelligence™ - Fourth Edition (Chinese) (Weschler, 2013; Chen et al., 2013); 6. Can comprehend phrases with at least two components.;
请登录查看1. Have hearing or vision impairment; 2. Have IQs below 49; 3. Cannot comprehend phrases with at least two components.;
请登录查看Department of Educational Psychology, The Chinese University of Hong Kong
/
Department of Educational Psychology, The Chinese University of Hong Kong的其他临床试验
The Chinese University of Hong Kong的其他临床试验
- Longitudinal and Moderating Effects of Repetitive Gain and Nonloss Framing on Self-Care, Digital Mental Health Platform Engagements, and Mental Health
- Feasibility, Acceptability and Effectiveness of a Tailored Multidimensional Intervention for Dementia Family Caregivers in Caregiving and Mental Health Crisis: A Pilot Randomised Controlled Trial
- One-step Rehydration Thawing Method in Frozen Embryo Transfer: A pragmatic randomized controlled clinical trial (ORT-FET-RCT)
- Feasibility and Acceptability of Cognitive Behavioural Stress Management Intervention (JoyMUM) for Pregnant Women: A Pilot Randomised Controlled Trial
- Building Resilience Against Rising Temperature - The Effect of High-Intensity Interval Exercise (HIIE) on Heat Tolerance, Thermoregulatory Adaptation, and Physical Fitness: A Comparative Randomized Controlled Trial
- The effect of Sodium-Glucose Cotransporter-2 Inhibitors and Dipeptidyl Peptidase-4 Inhibitors on Diabetic Retinal Disease
- 运动与脑刺激疗愈:促进居住于分间楼宇单位的注意力缺陷多动障碍儿童症状控制的三臂随机对照试验
- Effects of Care partner Online Programme for Managing BPSD and Enhancing Wellbeing (COPE‑BPSD)
- Air purifier and respiratory outcomes in childhood asthma in compromised housing environments: a hybrid effectiveness-implementation trial
- To investigate structural variations (SVs) in autism spectrum disorder (ASD) and related endophenotypes
- Young Adult Community Health Advisor (YACHA)-led Project to Promote Anti-drug Awareness among South Asian Youths and their Family in Hong Kong
- Effects of High-Intensity Interval Training on Physical Fitness, Cognitive and Mental Health in Hong Kong Adolescents with Intellectual Disabilities: A Cluster-Randomized Controlled Trial
- A self-determination theory-based interprofessional intervention to improve diabetes management in the primary health care setting of Hong Kong
- The Effects of Low‐ and High‐Glycemic Index Sport Nutrition Bars on Metabolism and High‐Intensity Interval Training Responses
- An innovative approach to combine intermittent dieting (INTD) with high-intensity interval exercise (HIIE) for curbing central obesity: A comparative randomized controlled trial
- Effectiveness of acceptance-based diabetes self-management (ACT-DSM) for adults with type 2 diabetes for improving diabetes distress and glycaemic control: A randomised controlled trial
- Effects of GABA with Butyrate, GABA/Butyrate-producing Synbiotics on Pain Relief in Fibromyalgia: A Phase II, Multi-Center, Double-Blinded, Randomized-Controlled Trial
- 一项关于声刺激增强慢波睡眠以改善失眠障碍睡眠质量的探索性研究
- The effects of art therapy-based intervention on anxiety children with haematological cancers: a randomised controlled trial
- Effectiveness of Digital CBT-I and BT-I combined ACT for Insomnia and Anxiety Symptoms in Youth: A Randomised Control Trial
最新临床资讯
-
一项5年临床安全随访研究启示:#脐带间充质干细胞(#hUC-MSCs)
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点,索弗度肽(survodutide)成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 60
-
摩熵咨询 20 3
-
颁布机构:国家卫生健康委办公厅、 2026-11-10
-
颁布机构:国家卫健委(原国家卫计委) 2026-11-10
-
颁布机构:国家药品审评中心(CDE) 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-04

